Insight Strategy Advisors (ISA) is a healthcare consulting firm headquartered in New York City. ISA provides commercial development strategy expertise to multinational biopharmaceutical companies — serving clients in New York, Philadelphia, Chicago, Boston, Raleigh, San Francisco, Los Angeles, London, Paris, Tokyo and Switzerland. ISA delivers value to clients through a diverse staff with expertise built from prior industry experience and direct industry knowledge gained from defining, creating, and executing commercial development strategies that maximize the economic value of therapeutic area franchises and products.
Entyvio’s clinical trials found no cases of progressive multifocal leukoencephalopathy, but FDA remains concerned because the product’s mechanism of action more >>
Thu, Dec 05, 2013 11:55:00 PM, Continue reading at the source
Depression candidate edivoxetine fails in three Phase III studies, marking a third recent blow to Lilly’s neuroscience pipeline efforts. more >>
Thu, Dec 05, 2013 10:40:00 PM, Continue reading at the source
Douglas Hawthorne, CEO of Texas Health Resources, has repeatedly made big bets on where the puck is going in healthcare, more >>
Thu, Dec 05, 2013 1:45:00 PM, Continue reading at the source